USCAP Presents:
Out with the Old and In with the New: An Updated Approach to the Cytologic Classification of Tumors

Multiple revisions and updates have recently been created for standardization of the cytologic classification of non-neoplastic and neoplastic processes in the pancreatobiliary tract, liver, thyroid, head and neck (including salivary gland), urine, kidneys, adrenal gland, lung and soft tissue. These standardized reporting schemes provide a framework for consistent categorization of cytopathology reports. They allow cytopathologists to convey clear, consistent diagnostic information, in language uniformly understood by pathologists and clinicians the world over. New developments in the diagnosis, grading and staging are not fully appreciated in the community, often leading to errors in diagnosis and impaired management. This case-based course will illustrate daily challenges, new guidelines, and practical clues to the proper handling of specimens from these sites along with accurate cytologic diagnosis of neoplasms in, and their distinction from, key cytomorphologic mimics. This will offer pathologists a unique perspective into the diagnostic morphometric signatures of key entities, which they can apply to daily practice even in the smaller hospital or private practice setting. The target audience for this course includes cytopathologists, general surgical pathologists who sign out cytopathology specimens, cytopathologists with special interest in pathology from these sites, and pathologists-in-training (residents and fellows).

USCAP Presents:
BELOW THE BELT: Pitfalls and New Entities in Anorectal, Urologic and Gynecologic Surgical Pathology and Cytopathology

Pathology of the lower anogenital tract, lower urinary tract, prostate, uterus, and cervix has advanced with the identification of relevant genes, better immunohistochemical markers, and the ability to readily detect human papillomavirus (HPV) using RNA in situ hybridization. New entities have recently been recognized, refinements to existing ones are possible, and new treatment, particularly immunotherapy, are available. Expert faculty will discuss newer entities and pitfalls in these areas, while also addressing diagnostic challenges in cytology and newly adopted classification schemes.